Use this medication as prescribed. Do not allow children to handle
or administer Clomicalm. For use in dogs only.
Use of Clomicalm is not intended to replace behavioral modification;
the medication is most effective when used along with a behavior modification
The recommended daily dose of Clomicalm is 0.9-1.8 mg/lb. Administer
this medication as a single dose or as a divided dose given twice daily.
Dividing the dose may reduce side effects.
- Hand-feed Clomicalm with a small amount of food to reduce vomiting.
- Give 5 mg daily to dogs weighing 2.75-5.5 lbs.
- Give 10 mg daily to dogs weighing 5.6-10.9 lbs.
- Give 20 mg daily to dogs weighing 11-22 lbs.
- Give 40 mg daily to dogs weighing 22.1-44 lbs.
- Give 80 mg daily to dogs weighing 44.1-88 lbs.
- Give 160 mg daily to dogs weighing 88.1-176 lbs.
- Reduce the dose under instruction by your veterinarian once symptoms
Frequency of Use:
Improvement in symptoms may not be evident for days or weeks. Do not
stop using this medication unless told to do so by your veterinarian.
Do not use for longer than 12 weeks unless instructed to do so by
your veterinarian. Withdrawal from Clomicalm should involve tapering
the dose while monitoring the dog for behavioral changes and withdrawal
Store Clomicalm at controlled room temperature, away from moisture,
and in the original container. Keep away from pets and children.
It is a violation of Federal Law to use this product
in a manner inconsistent with its labeling.
Clomicalm reduces symptoms of anxiety by affecting levels of serotonin
and norepinephrine in the central nervous system of dogs. Although Clomicalm
may cause some drowsiness and lethargy, this sedative effect is not
responsible for the reduction in symptoms.
Clomicalm Tablets are available in strengths of 5 mg, 20 mg, 40 mg,
and 80 mg. The tablets are contained in color-coded packaging.
Keep this product out of reach of children and
animals. Do not use or store in or near open flame or heat.
Clomicalm is only for use in dogs 6 months or
older. Do not give to other animals. Do not use in humans. Seek immediate
medical attention for ingestion by humans, especially children. Overdose
in humans causes convulsions, tachycardia, and arrhythmia.
CAUTION: Do not give Clomicalm to dogs with a known hypersensitivity
to any tricyclic antidepressants. This medication is contraindicated
for dogs with a history of seizures disorders. Do not use if your dog
is currently being treated with medication that lowers the seizure threshold.
Do not use this medication in male breeding dogs.
Do not give to dogs currently undergoing treatment
with a monoamine oxidase inhibitor (MAOI). Do not use within 14 days
before or after treatment with an MAOI.
Use cautiously in dogs with urinary retention,
increased intraocular pressure, narrow angle glaucoma, and reduced gastrointestinal
motility. Consult your veterinarian before using in dogs with a history
of liver disease.
It is not known if Clomicalm is safe for use in
pregnant and lactating females.
Side effects of Clomicalm may include lethargy,
emesis, diarrhea, constipation, reduced appetite, dry mouth, polydipsia,
tremors, aggression, seizures, polyuria, anisocoria, and hyperthermia.
Warranty and Manufacturer Information:
Manufactured for: Novartis Animal Health US, Inc.,
Greensboro, NC 27408, USA
NADA # 141-120, Approved by FDA
©2008 Novartis Animal Health US, Inc.
Clomicalm is a registered trademark of Novartis
NAC No.: 11310005